Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine

Aklima Akter; Md. Arifur Rahman; Md. Zakiur Rahman; Mirtyunjoy Acharjee; Farjana Sultana; Saurab Kishore Munshi

doi:doi:10.11648/j.ejcbs.20220803.13

| Peer-Reviewed

Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine

Aklima Akter, Md. Arifur Rahman, Md. Zakiur Rahman, Mirtyunjoy Acharjee, Farjana Sultana, Saurab Kishore Munshi

Published in European Journal of Clinical and Biomedical Sciences (Volume 8, Issue 3)

Received: 21 May 2022 Accepted: 6 June 2022 Published: 16 June 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The corona virus disease-2019 (COVID-19), also known as the corona pandemic, is an ongoing public health emergency caused by coronavirus 2019 (COVID-19), which is spread by the transmission of coronavirus-2, which causes severe acute respiratory syndrome. The first incidence of COVID-19 in Bangladesh was reported on March 7, 2020. There were 450,273,828 diagnoses worldwide as of March 9, 2022, with 1,948,471 in Bangladesh. To better understand the current state of COVID-19 in Brahmanbaria, a retrospective study was done at Brahmanbaria Medical College with COVID-19-suspected patients. Methods: A total of 600 oropharyngeal and nasopharyngeal swab samples were taken from COVID-19 suspected person, as well as the appropriate proceedings were identified using a reverse transcriptase–polymerase chain reaction assay. We found 193 (32%) of positive cases that represent similarity with national. Among 193 positive cases which 127 (66%) was male that is greater amount from female. Out of 193 positive cases 114 were symptomatic that is 59% and 79 were asymptomatic which is 41%. Asymptomatic infection is more frightening because it is difficult to identify patients. And Odds ratio is 0.9, it indicates a protective effect of vaccination against COVID-19. That reduced risk is 1-odds so will be 10 percent reduced risk of exposure.

Published in	European Journal of Clinical and Biomedical Sciences (Volume 8, Issue 3)
DOI	10.11648/j.ejcbs.20220803.13
Page(s)	44-48
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

COVID-19, NP, OP, Odds Ratio, RT-PCR

References

[1]	Wu C, Chen X, Cai Y, Xai J, Zhou X, Xu S. Risk Factors associated with acute respiratory distress syndrome and death patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020: 180: 934-43.
[2]	Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D. Clinical characteristics of laboratory-confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single-center analysis. Travel Med Infect Dis. 2020. doi: 10.1016/j.tmaid.2020.101606.
[3]	Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020. doi: 10.1016/S0140-6736 (20)30211-7.
[4]	Dong E, Du H, Gardner L. An interactive Web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20: 533-4.
[5]	Anwar S, Nasrullah M and Hosen MJ. COVID-19 and Bangladesh: Challenges and How to Address Them. Front. Public Health 2020; 8: 154. doi: 10.3389/fpubh.2020.00154.
[6]	Timeline of the COVID-19 pandemic in Bangladesh. Available from: https://en.wikipedia.org/wiki/Timeline_of_the_COVID-19_pandemic_in_Bangladesh.
[7]	https://www.worldometers.info/coronavirus/09 March 9, 2022
[8]	https://www.aninews.in/news/world/asia/COVID-19-bangladesh-reports-first-case-of-omicron-variant20211211193535/
[9]	https://www.who.int/publications/m/item/weekly-epidemiological-update-on-COVID-19---25-january-2022
[10]	Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020Mar; 25 (3): 278. DOI: https://doi.org/10.1111/tmi.13383.PubmedPMID: 32052514.
[11]	Yuanyuan Dong, Xi Mo, Yabin Hu, Xin Qi, Fang Jiang, Zhongyi Jiang, and Shilu Tong. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics, 2020.
[12]	Dawei W, Bo Hu, Chang Hu, Fangfang Z, Xing L, Jing Z et al Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 323 (11): 1061–1069, 03 2020.
[13]	Tan SC, Yiap BC. DNA, RNA, and protein extraction: The past and the present. J Biomed Biotechnol 2009; 2009: 574398. doi: 10.1155/2009/574398.
[14]	Doyle K. The source of discovery: Protocols and application Guide. 1996. Madison, Wis, USA: PROMEGA; 1996.
[15]	McHugh ML. The odds ratio: calculation, usage, and interpretation. Biochemia Medica 2009; 19 (2): 120–6.
[16]	Akter A, Tabassum N, Rahman A. Prevalence of severe acute respiratory syndrome Coronavirus-2 among the young people and association between diabetes, hypertension, and severe acute respiratory syndrome Coronavirus-2. Biomed Biotechnol Res J 2021;5:134-8
[17]	Akter, et al. Prevalence of COVID-19 Positive Cases Diagnosed By Real Time Polymerase Chain Reaction and Mortality from SARS-Cov-2 among Suspected Population International Journal of Medical Science and Clinical Research Volume 01 (10) December 2021 Pp 329-333 DOI: https://doi.org/10.47191/ijmscrs/v1-i10-04.
[18]	Daniel P. Oran, AM. Prevalence of Asymptomatic SARS-CoV-2 Infection. September 2020: 173 (4) https://doi.org/10.7326/M20-3012
[19]	USS Roosevelt's asymptomatic cases helping scientists understand virus. NBC 7 San Diego. April 2020. Accessed at www.nbcsandiego.com/videos/uss-roosevelts-asymptomatic-cases-could-help-scientists-understand-virus/2309131 on 21 April 2020.
[20]	Sah et al. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis https: //doi.org/10.1073/pnas.2109229118.
[21]	A. Kronbichler et al. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis International Journal of Infectious Diseases 98 (2020) 180–186.
[22]	A B Suthar, J Wang, R E Wiegand, S Griffing. Public health impact of COVID-19 vaccination in the US: observational study. the bmj. https://doi.org/10.1136/bmj-2021-.069317.

Cite This Article

Plain Text BibTeX RIS

APA Style

Aklima Akter, Md. Arifur Rahman, Md. Zakiur Rahman, Mirtyunjoy Acharjee, Farjana Sultana, et al. (2022). Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine. European Journal of Clinical and Biomedical Sciences, 8(3), 44-48. https://doi.org/10.11648/j.ejcbs.20220803.13

Copy | Download

ACS Style

Aklima Akter; Md. Arifur Rahman; Md. Zakiur Rahman; Mirtyunjoy Acharjee; Farjana Sultana, et al. Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine. Eur. J. Clin. Biomed. Sci. 2022, 8(3), 44-48. doi: 10.11648/j.ejcbs.20220803.13

Copy | Download

AMA Style

Aklima Akter, Md. Arifur Rahman, Md. Zakiur Rahman, Mirtyunjoy Acharjee, Farjana Sultana, et al. Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine. Eur J Clin Biomed Sci. 2022;8(3):44-48. doi: 10.11648/j.ejcbs.20220803.13

Copy | Download

@article{10.11648/j.ejcbs.20220803.13,
  author = {Aklima Akter and Md. Arifur Rahman and Md. Zakiur Rahman and Mirtyunjoy Acharjee and Farjana Sultana and Saurab Kishore Munshi},
  title = {Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine},
  journal = {European Journal of Clinical and Biomedical Sciences},
  volume = {8},
  number = {3},
  pages = {44-48},
  doi = {10.11648/j.ejcbs.20220803.13},
  url = {https://doi.org/10.11648/j.ejcbs.20220803.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejcbs.20220803.13},
  abstract = {The corona virus disease-2019 (COVID-19), also known as the corona pandemic, is an ongoing public health emergency caused by coronavirus 2019 (COVID-19), which is spread by the transmission of coronavirus-2, which causes severe acute respiratory syndrome. The first incidence of COVID-19 in Bangladesh was reported on March 7, 2020. There were 450,273,828 diagnoses worldwide as of March 9, 2022, with 1,948,471 in Bangladesh. To better understand the current state of COVID-19 in Brahmanbaria, a retrospective study was done at Brahmanbaria Medical College with COVID-19-suspected patients. Methods: A total of 600 oropharyngeal and nasopharyngeal swab samples were taken from COVID-19 suspected person, as well as the appropriate proceedings were identified using a reverse transcriptase–polymerase chain reaction assay. We found 193 (32%) of positive cases that represent similarity with national. Among 193 positive cases which 127 (66%) was male that is greater amount from female. Out of 193 positive cases 114 were symptomatic that is 59% and 79 were asymptomatic which is 41%. Asymptomatic infection is more frightening because it is difficult to identify patients. And Odds ratio is 0.9, it indicates a protective effect of vaccination against COVID-19. That reduced risk is 1-odds so will be 10 percent reduced risk of exposure.},
 year = {2022}
}

Copy | Download

TY - JOUR
T1 - Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine
AU - Aklima Akter
AU - Md. Arifur Rahman
AU - Md. Zakiur Rahman
AU - Mirtyunjoy Acharjee
AU - Farjana Sultana
AU - Saurab Kishore Munshi
Y1 - 2022/06/16
PY - 2022
N1 - https://doi.org/10.11648/j.ejcbs.20220803.13
DO - 10.11648/j.ejcbs.20220803.13
T2 - European Journal of Clinical and Biomedical Sciences
JF - European Journal of Clinical and Biomedical Sciences
JO - European Journal of Clinical and Biomedical Sciences
SP - 44
EP - 48
PB - Science Publishing Group
SN - 2575-5005
UR - https://doi.org/10.11648/j.ejcbs.20220803.13
AB - The corona virus disease-2019 (COVID-19), also known as the corona pandemic, is an ongoing public health emergency caused by coronavirus 2019 (COVID-19), which is spread by the transmission of coronavirus-2, which causes severe acute respiratory syndrome. The first incidence of COVID-19 in Bangladesh was reported on March 7, 2020. There were 450,273,828 diagnoses worldwide as of March 9, 2022, with 1,948,471 in Bangladesh. To better understand the current state of COVID-19 in Brahmanbaria, a retrospective study was done at Brahmanbaria Medical College with COVID-19-suspected patients. Methods: A total of 600 oropharyngeal and nasopharyngeal swab samples were taken from COVID-19 suspected person, as well as the appropriate proceedings were identified using a reverse transcriptase–polymerase chain reaction assay. We found 193 (32%) of positive cases that represent similarity with national. Among 193 positive cases which 127 (66%) was male that is greater amount from female. Out of 193 positive cases 114 were symptomatic that is 59% and 79 were asymptomatic which is 41%. Asymptomatic infection is more frightening because it is difficult to identify patients. And Odds ratio is 0.9, it indicates a protective effect of vaccination against COVID-19. That reduced risk is 1-odds so will be 10 percent reduced risk of exposure.
VL - 8
IS - 3
ER -

Copy | Download

Author Information

Aklima Akter

Department of Microbiology, Brahmanbaria Medical College, Brahmanbaria, Bangladesh
Md. Arifur Rahman

Department of Microbiology, Brahmanbaria Medical College, Brahmanbaria, Bangladesh
Md. Zakiur Rahman

Department of Microbiology, Brahmanbaria Medical College, Brahmanbaria, Bangladesh
Mirtyunjoy Acharjee

Department of Microbiology, Stamford University Bangladesh, Dhaka, Bangladesh
Farjana Sultana

Department of Oral and Maxillofacial Surgery, Dhaka Dental College and Hospital, Dhaka, Bangladesh
Saurab Kishore Munshi

Department of Microbiology, Stamford University Bangladesh, Dhaka, Bangladesh

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Aklima Akter, Md. Arifur Rahman, Md. Zakiur Rahman, Mirtyunjoy Acharjee, Farjana Sultana, et al. (2022). Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine. European Journal of Clinical and Biomedical Sciences, 8(3), 44-48. https://doi.org/10.11648/j.ejcbs.20220803.13

Copy | Download

ACS Style

Aklima Akter; Md. Arifur Rahman; Md. Zakiur Rahman; Mirtyunjoy Acharjee; Farjana Sultana, et al. Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine. Eur. J. Clin. Biomed. Sci. 2022, 8(3), 44-48. doi: 10.11648/j.ejcbs.20220803.13

Copy | Download

AMA Style

Aklima Akter, Md. Arifur Rahman, Md. Zakiur Rahman, Mirtyunjoy Acharjee, Farjana Sultana, et al. Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine. Eur J Clin Biomed Sci. 2022;8(3):44-48. doi: 10.11648/j.ejcbs.20220803.13

Copy | Download

@article{10.11648/j.ejcbs.20220803.13,
  author = {Aklima Akter and Md. Arifur Rahman and Md. Zakiur Rahman and Mirtyunjoy Acharjee and Farjana Sultana and Saurab Kishore Munshi},
  title = {Estimation of COVID-19 Prevalence in a Tertiary Care Hospital in Bangladesh & Impact of COVID-19 Vaccine},
  journal = {European Journal of Clinical and Biomedical Sciences},
  volume = {8},
  number = {3},
  pages = {44-48},
  doi = {10.11648/j.ejcbs.20220803.13},
  url = {https://doi.org/10.11648/j.ejcbs.20220803.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ejcbs.20220803.13},
  abstract = {The corona virus disease-2019 (COVID-19), also known as the corona pandemic, is an ongoing public health emergency caused by coronavirus 2019 (COVID-19), which is spread by the transmission of coronavirus-2, which causes severe acute respiratory syndrome. The first incidence of COVID-19 in Bangladesh was reported on March 7, 2020. There were 450,273,828 diagnoses worldwide as of March 9, 2022, with 1,948,471 in Bangladesh. To better understand the current state of COVID-19 in Brahmanbaria, a retrospective study was done at Brahmanbaria Medical College with COVID-19-suspected patients. Methods: A total of 600 oropharyngeal and nasopharyngeal swab samples were taken from COVID-19 suspected person, as well as the appropriate proceedings were identified using a reverse transcriptase–polymerase chain reaction assay. We found 193 (32%) of positive cases that represent similarity with national. Among 193 positive cases which 127 (66%) was male that is greater amount from female. Out of 193 positive cases 114 were symptomatic that is 59% and 79 were asymptomatic which is 41%. Asymptomatic infection is more frightening because it is difficult to identify patients. And Odds ratio is 0.9, it indicates a protective effect of vaccination against COVID-19. That reduced risk is 1-odds so will be 10 percent reduced risk of exposure.},
 year = {2022}
}

Copy | Download